- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 00:05 | NT PHARMA (01011): SUPPLEMENTAL ANNOUNCEMENT RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR | 1 | HKEx | ||
| Fr | NT PHARMA (01011): SUPPLEMENTAL ANNOUNCEMENT DISCLOSURE OF JUDICIAL PROCEDURE RECORDS OF A DIRECTOR | - | HKEx | ||
| CHINA NT PHARMA Aktie jetzt für 0€ handeln | |||||
| 12.05. | NT PHARMA (01011): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
| 08.05. | NT PHARMA (01011): CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND CHANGES IN COMPOSITION OF BOARD COMMITTEES | 2 | HKEx | ||
| 08.05. | NT PHARMA (01011): PAST NOTIFIABLE TRANSACTIONS AND CONNECTED TRANSACTIONS IN RELATION TO THE PROVISION OF FINANCIAL ASSISTANCE AND LOAN AGREEMENTS AND ... | 1 | HKEx | ||
| 30.04. | NT PHARMA (01011): QUARTERLY UPDATES ON THE IMPLEMENTATION OF ACTION PLANS TO RESOLVE THE DISCLAIMER OF OPINION | - | HKEx | ||
| 30.04. | NT PHARMA (01011): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDER | 1 | HKEx | ||
| 30.04. | NT PHARMA (01011): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER | - | HKEx | ||
| 30.04. | NT PHARMA (01011): FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING | - | HKEx | ||
| 30.04. | NT PHARMA (01011): NOTICE OF ANNUAL GENERAL MEETING | - | HKEx | ||
| 30.04. | NT PHARMA (01011): ANNUAL GENERAL MEETING | - | HKEx | ||
| 30.04. | NT PHARMA (01011): ANNUAL REPORT 2025 | - | HKEx | ||
| 13.04. | NT PHARMA (01011): APPOINTMENT OF NON-EXECUTIVE DIRECTOR | - | HKEx | ||
| 31.03. | NT PHARMA (01011): ANNOUNCEMENT OF AUDITED ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025 | - | HKEx | ||
| 30.03. | NT PHARMA (01011): PROFIT WARNING REDUCTION IN LOSS SUPPLEMENTAL ANNOUNCEMENT | 1 | HKEx | ||
| 25.03. | NT PHARMA (01011): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 25.03. | NT PHARMA (01011): COMPLETION OF MAJOR TRANSACTION IN RELATION TO THE ACQUISITION OF 100% OF THE ISSUED SHARES IN THE TARGET COMPANIES INVOLVING THE ISSUE ... | 1 | HKEx | ||
| 18.03. | NT PHARMA (01011): DATE OF BOARD MEETING | - | HKEx | ||
| 26.02. | NT PHARMA (01011): PROFIT WARNING REDUCTION IN LOSS | - | HKEx | ||
| 10.02. | NT PHARMA (01011): TERMINATION OF THE SUBSCRIPTION AGREEMENTS IN RELATION TO THE ISSUE OF CONVERTIBLE BONDS UNDER GENERAL MANDATE AND RESUMPTION OF TRADING | - | HKEx |
1 2 Weiter >>
32 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,802 | -1,13 % | Bioxyne Aktie in Hochform: Aurora-Deal und 50-Millionen-AUD-Vertrag könnten neues Wachstum entfachen | ||
| CANOPY GROWTH | 0,882 | +4,35 % | Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today | ||
| TILRAY BRANDS | 4,550 | +1,22 % | Tilray Brands, Inc.: BrewDog Shakes Up RTD Shelves Across the UK with New Nostalgia-Led Wonderland Cocktails | Introducing Pear Drop Margarita & Fizzy Toffee Apple Martini
ELLON, Scotland, May 14, 2026 (GLOBE NEWSWIRE) -- BrewDog, by Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is shaking up the ready-to-drink... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| SINOPHARM | 1,970 | -0,51 % | Sinopharm expands its international presence | ||
| CSPC PHARMA | 0,824 | +1,07 % | CSPC PHARMA (01093): VOLUNTARY ANNOUNCEMENT - HIGHLY SELECTIVE KAT6 INHIBITOR (SYH2095 TABLETS) OBTAINS CLINICAL TRIAL APPROVAL IN CHINA | ||
| ORAMED PHARMACEUTICALS | 3,835 | +2,54 % | ORAMED PHARMACEUTICALS INC. - 10-Q, Quarterly Report | ||
| ADASTRA | 0,115 | -100,00 % | CSE Bulletin: Suspensions - Adastra Holdings Ltd., CAT Strategic Metals Corporation, Greenrise Global Brands Inc., StickIt Technologies Inc. | Le 12 mai/May 2026
Effective immediately, the following companies are suspended pursuant to CSE Policy 3. The suspensions are considered Regulatory Halts as defined in National Instrument 23-101... ► Artikel lesen | |
| CATALYST PHARMACEUTICALS | 26,700 | -0,74 % | Catalyst Pharmaceuticals, Inc.: Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results | Delivered Q1 2026 Total Revenues of $149.4 MillionResults include 28% YoY Increase in Net Product Revenues from FIRDAPSE® & AGAMREE® Reported Cash and Cash Equivalents of $755.9 Million and No Funded... ► Artikel lesen | |
| BAYER | 38,830 | +0,80 % | Übernahme bei Bayer! Schock bei Rheinmetall! Chance bei MustGrow Aktie! | Erstellt und veröffentlicht im Auftrag von MustGrow Biologics Corp. Die Blockade in der Straße von Hormus ist ein Stresstest für die globale Ernährungssicherheit. Die Lieferketten der Düngemittelindustrie... ► Artikel lesen | |
| MERCK KGAA | 121,70 | +0,81 % | DAX-Check LIVE: Auto1, Brenntag, E.on, Merck, RWE, SFC Energy, SMA Solar, Verbio im Fokus | Die festgefahrene Lage im Nahen Osten hat den deutschen Aktienmarkt weiter belastet. Je länger der Konflikt andauert, desto größer werden die Sorgen vor wirtschaftlichen Folgen. Steigende Ölpreise und... ► Artikel lesen | |
| NOVO NORDISK | 38,350 | +0,04 % | Novo Nordisk: Erste Früchte der Investitionsoffensive - trägt die Story trotz Wachstumsrally noch weiter? | Novo Nordisk hat im ersten Quartal 2024 eindrucksvoll unter Beweis gestellt, dass die massiven Investitionen in Produktionskapazitäten beginnen, sich auszuzahlen. Trotz hoher Bewertungskennzahlen sehen... ► Artikel lesen | |
| ETON PHARMACEUTICALS | 32,860 | -0,09 % | Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO (miltefosine) | IMPAVIDO is the first and only FDA-approved oral therapy for visceral, cutaneous, and mucosal leishmaniasis caused by specific Leishmania speciesLeishmaniasis is a rare but potentially life-threatening... ► Artikel lesen | |
| BRIGHT MINDS BIOSCIENCES | 74,54 | 0,00 % | Bright Minds Biosciences Announces Closing of US$175 Million Public Offering | NEW YORK, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company") today closed its recently announced public offering of 1,945... ► Artikel lesen | |
| AQUESTIVE THERAPEUTICS | 4,090 | 0,00 % | Aquestive Therapeutics, Inc.: Aquestive Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Reaffirms guidance to resubmit Anaphylm (dibutepinephrine) sublingual film NDA in Q3 2026Affirms existing clinical data is sufficient for submitting regulatory applications in Canada, European Union... ► Artikel lesen |
Das Unternehmen CHINA NT PHARMA GROUP CO LTD kann der Branche Pharma zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CHINA NT PHARMA GROUP CO LTD finden Sie auf Wallstreet Online.